Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 30th, there was short interest totaling 34,199 shares, a decrease of 40.6% from the September 15th total of 57,529 shares. Approximately 1.1% of the shares of the stock are sold short. Based on an average trading volume of 40,379 shares, the days-to-cover ratio is presently 0.8 days.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the business. WMS Group LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $4,255,000. Valeo Financial Advisors LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at approximately $296,000. Breakwater Capital Group purchased a new stake in Invesco Nasdaq Biotechnology ETF in the first quarter valued at $200,000. Finally, Ascentis Independent Advisors acquired a new position in Invesco Nasdaq Biotechnology ETF in the first quarter valued at approximately $31,000.
Invesco Nasdaq Biotechnology ETF Trading Down 2.7%
Shares of IBBQ stock traded down $0.94 on Friday, reaching $33.72. The company’s stock had a trading volume of 17,878 shares, compared to its average volume of 31,318. Invesco Nasdaq Biotechnology ETF has a 1 year low of $25.57 and a 1 year high of $36.84. The company has a market capitalization of $108.92 million, a price-to-earnings ratio of 17.03 and a beta of 0.60. The stock’s fifty day simple moving average is $34.96 and its 200-day simple moving average is $32.14.
Invesco Nasdaq Biotechnology ETF Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Monday, September 21st were given a $0.2304 dividend. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.0342. This represents a $0.92 annualized dividend and a yield of 2.7%. The ex-dividend date was Monday, September 21st.
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
